Skip to main content

Pharmaceutical Care in Type-2 Diabetes

  • Chapter
  • First Online:
The Pharmacist Guide to Implementing Pharmaceutical Care
  • 2052 Accesses

Abstract

There are many opportunities for pharmacists to make valuable contributions to the care of patients with diabetes . The application of a systematic pharmaceutical care process as outlined in this chapter will facilitate identification of a range of DRPs which may be preventing the patient from deriving the maximum benefit to be gained from their pharmacotherapy . Pharmacists should appreciate the needs of their patients and establish systems and infrastructure to permit the provision and documentation of effective pharmaceutical care .

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zaccardi F, Webb DR, Yates T, Davies MJ. Pathophysiology of type 1 and Type 2 Diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016;92:63–9.

    Article  CAS  Google Scholar 

  2. American Diabetes Association Standards of medical care in diabetes: Diabetes care [Internet]. 2017 29 June 2017; 40(Supplement 1). Available from http://care.diabetesjournals.org/content/diacare/suppl/2016/12/15/40.Supplement_1.DC1/DC_40_S1_final.pdf.

  3. International Diabetes Federation: About diabetes 2017. Available from https://www.idf.org/about-diabetes/what-is-diabetes.html.

  4. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–88.

    Article  CAS  Google Scholar 

  5. Clement M, Bhattacharyya O, Conway JR. Is tight glycemic control in really worthwhile? YES. Can Fam Physician. 2009;55:580–2.

    PubMed  Google Scholar 

  6. Cornell S. Key considerations in pharmacotherapy for Type 2 Diabetes mellitus: a multiple target organ approach. J Clin Pharm Thera. 2012;37:254–9.

    Article  CAS  Google Scholar 

  7. Upadhyay J, Polyzos SA, Perakakis N, Thakkar B, Paschoub SA, Katsiki N, Underwood P, Park KH, Seufert J, Kangg ES, Sternthal E, Karagiannis A, Mantzoros CS. Pharmacotherapy of Type 2 Diabetes: an update. Metabolism. 2018;78:13–42. https://doi.org/10.1016/j.metabol.2017.08.010.

    Article  CAS  PubMed  Google Scholar 

  8. Krass I, Hebing R, Mitchell B, Hughes J, Peterson G, Song YC, et al. Diabetes management in an Australian primary care population. J Clin Pharm Thera. 2011;36:664–72.

    Article  CAS  Google Scholar 

  9. Eichenberger PM, Haschke M, Lampert ML, Hersberger KE. Drug-related problems in diabetes and transplant patients: an observational study with home visits. Int J Clin Pharm. 2011;33:815–23.

    Article  CAS  Google Scholar 

  10. Al Hamid A, Aslanpour Z, Aljadhey H, Ghaleb M. Hospitalisation resulting from medicine-related problems in adult patients with Cardiovascular diseases and diabetes in the United Kingdom and Saudi Arabia. Int J Environ Res Public Health. 2016;13(5).

    Article  Google Scholar 

  11. Mitchell B, Armour C, Lee M, Song YJ, Stewart K, Peterson G, et al. Diabetes Medication Assistance Service: The Pharmacist’s Role in Supporting Patient Self-Management of Type 2 Diabetes (T2DM). Patient Educ Couns. 2011;83:288–94.

    Article  Google Scholar 

  12. International Diabetes Federation. Self-monitoring of blood glucose in non-insulin-treated Type 2 Diabetes 2009 [cited 2017 August 21]. Available from www.idf.org and at www.smbg-iwg.com.

  13. Chaudhury A, Duvoor C, Dendi R, Sena V, Kraleti S, Chada A, et al. Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front Endocrinol. 2017;8. https://doi.org/10.3389/fendo.2017.00006.

  14. Hughes J, Wibowo Y, Sunderalnd B, Hoti K. The role of the pharmacist in the management of type 2 diabetes: current insights and future directions. Integ Pharm Res Pract. 2017;6:15–27.

    Article  Google Scholar 

  15. Berenguer B, La Casa C, de la Matta M, Martin-Calero MJ. Pharmaceutical care: past, present and future. Curr Pharm Design. 2004;10:3931–46.

    Article  CAS  Google Scholar 

  16. Polonsky W, Henry R. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–307.

    Article  Google Scholar 

  17. Pharmaceutical Care Network Europe. PCNE Classification for Drug related problems. 2017. Available from http://www.pcne.org/upload/files/215_PCNE_classification_V8-01.pdf.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ines Krass .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Krass, I., Hoti, K. (2019). Pharmaceutical Care in Type-2 Diabetes. In: Alves da Costa, F., van Mil, J., Alvarez-Risco, A. (eds) The Pharmacist Guide to Implementing Pharmaceutical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-92576-9_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92576-9_28

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92575-2

  • Online ISBN: 978-3-319-92576-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics